Brief Psychiatric Rating Scale

(redirected from BPRS)
Also found in: Acronyms.

Brief Psychiatric Rating Scale

A popular, widely used rating scales for adults with schizophrenia and psychosis, which includes a comprehensive 3-phase interview and an 18-item symptom evaluation. The BPRS rates the severity of psychotic symptoms on a scale from 0 (no symptoms), to 126 (major disease).
Segen's Medical Dictionary. © 2012 Farlex, Inc. All rights reserved.
References in periodicals archive ?
To further demonstrate the effectiveness of pixel category, we recalculate its BPRs including holes and obtain the average BPRs for each pixel subset shown in Table 2.
ECT was extremely successful, and her symptoms considerably improved after the 14 sessions, with remarkable reductions in BPRS and BFCRS scores.
15, 30, and 50 Hz were chosen as the studied milling frequencies, where the milling time and ball-to-powder mass ratio (BPR) vary from 15 to 120 min and 4: 1 to 20: 1, respectively.
Regarding the BPRS subscales in the post bolus phase, scores in the SNP sessions were lower than those in the placebo session, showing statistically significant differences for the subscales anxiety-depression (t = 2.02, df = 34, p = 0.05), thought disorder (t = 2.46, df =34,p = 0.02) and activation (t = 2.02, df = 34, p = 0.05), with a tendency to a significant difference between SNP and placebo in the emotional withdrawal subscale (t = 1.96, df = 34, p = 0.06) (Figure 2).
None of the clinical variables (SANS, SAPS, BPRS, and GAF scores, age, and duration of illness) were significantly correlated with grey matter volume of insula in patients diagnosed with schizophrenia (P > 0.004; Table 3 and Fig.
BDI-II score, BPRS score, anxiety-depression factor score, and hostility-suspicion factor score in the PD subgroup were significantly higher than those in the NPD subgroup (all P < 0.01).
(2009) [57] assessed depression and anxiety factors using the Brief Psychiatric Rating Scale (BPRS) between index parents and a normative comparison group and only found a statistically significant difference in the depression factor with index parents scoring higher (ES range: 0.29-0.44).
[alpha]-methyldopa, which interferes with the synthesis of both norepinephrine and dopamine, in conjunction with chlorpromazine, a D2 dopamine receptor antagonist, has been shown to be effective at treating schizophrenic behaviors as measured by the Inpatient Multidimensional Psychiatric Scale (IMPS) and the Brief Psychiatric Rating Scale (BPRS) [153].